An unusual case of post-kala-azar dermal leishmaniasis in a patient with HIV and visceral leishmaniasis co-infection-Reference-Cited by-同舟云学术

An unusual case of post-kala-azar dermal leishmaniasis in a patient with HIV and visceral leishmaniasis co-infection

Published:2019-09-27 Issue:12 Volume:30 Page:1221-1223
ISSN:0956-4624
Container-title:International Journal of STD & AIDS
language:en
Short-container-title:Int J STD AIDS

Author:

Elliott Tamara¹^ORCID,Simpson Jacqueline²,Naresh Kikkeri N³,Lockwood Diana⁴,Bailey Angela C¹

Affiliation:

1. HIV and Sexual Health Medicine, Imperial College Healthcare NHS Trust, London, UK

2. Dermatology, Imperial College Healthcare NHS Trust, London, UK

3. Histopathology, Imperial College Healthcare NHS Trust, London, UK

4. Infectious Diseases and Tropical Medicine, Hospital for Tropical Diseases, London, UK

Abstract

Visceral leishmaniasis (VL) is a vector-borne disease caused by Leishmania donovani complex. Post-kala-azar dermal leishmaniasis (PKDL) is a rash that can occur following treatment for VL due to L. donovani species. We describe an unusual case of PKDL occurring during treatment for Leishmania infantum VL in a patient with human immunodeficiency virus-co infection.

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Public Health, Environmental and Occupational Health,Dermatology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0956462419868617

Reference11 articles.

1. Post-kala-azar dermal leishmaniasis

2. New insights into leishmaniasis in the immunosuppressed

3. Visceral leishmaniosis in immunocompromised host: an update and literature review

4. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unusual Observations in Leishmaniasis—An Overview;Pathogens;2023-02-10

2. Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIV;AIDS;2022-07-16